Improving tuberculosis diagnostics to enhance patient care
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
This study is working on creating better and more affordable tests for tuberculosis (TB) so that more people can get the right diagnosis and treatment, especially in areas where TB is common.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10867290 on NIH RePORTER |
What this research studies
This research focuses on developing better diagnostic tests for tuberculosis (TB) to ensure that more patients are accurately diagnosed and treated. It addresses the current limitations of TB diagnostics, such as low sensitivity and high costs, which prevent effective treatment in many high-burden countries. By identifying and evaluating promising new technologies, the project aims to close the diagnostic gap and improve health outcomes for TB patients. The research will involve collaboration with clinical study sites to test and provide feedback on these novel diagnostics.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in high-burden countries who are suspected of having tuberculosis or are at high risk for the disease.
Not a fit: Patients who do not have tuberculosis or are not at risk for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and accessible TB diagnostics, ultimately reducing transmission and mortality rates.
How similar studies have performed: Previous research has shown promise in developing improved diagnostics for infectious diseases, indicating potential success for this novel approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Nahid, Payam — University of California, San Francisco
- Study coordinator: Nahid, Payam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.